ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,681Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 118

$791K Total Retail Price of All Prescriptions

Rank: 8 out of 118

549 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 549 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

7% of this provider’s 549 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 6,420 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 64%.

Prescription Price

$103 was the average price of a prescription from this provider, compared to $170 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 328 286 1 12
FUROSEMIDE 278 249 2 7
SIMVASTATIN 271 232 3 8
SPIRIVA 209 193 4 1
METOPROLOL TARTRATE 193 147 5 16
LEVOTHYROXINE SODIUM 179 160 6 10
ATORVASTATIN CALCIUM 156 136 7 17
OMEPRAZOLE 147 128 8 11
ZOLPIDEM TARTRATE 143 126 9 22
ADVAIR DISKUS 142 111 10 2
WARFARIN SODIUM 142 127 10 15
PREDNISONE 137 108 12 4
AMLODIPINE BESYLATE 125 118 13 9
METFORMIN HCL 120 82 14 23
TRAMADOL HCL 99 99 15 42
POTASSIUM CHLORIDE 97 87 16 29
PROAIR HFA 89 60 17 3
DIOVAN 88 76 18 32
HYDROCODONE-ACETAMINOPHEN 88 79 S3 18 38
CELEBREX 75 56 20 67
HYDROCHLOROTHIAZIDE 74 73 21 20
DONEPEZIL HCL 70 70 22 31
CRESTOR 66 62 23 37
SERTRALINE HCL 65 65 24 33
NEXIUM 64 59 25 28
TAMSULOSIN HCL 63 61 26 40
RAMIPRIL 62 61 27 137
LOVASTATIN 60 60 28 64
OXYCODONE HCL-ACETAMINOPHEN 59 30 S2 29 100
GABAPENTIN 57 45 30 25
PANTOPRAZOLE SODIUM 55 53 31 35
ALLOPURINOL 55 51 31 50
DIGOXIN 54 30 33 52
TRAZODONE HCL 51 28 34 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 48 34 94
CITALOPRAM HBR 50 32 36 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 3, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.